Parents urged to vaccinate children in wake of UK pneumonia epidemic
Pneumonia epidemic peaks historically occur every four to seven years, with the last epidemic of pneumonia in the UK occurring …
Post
-
-
Vaccine clinical trial spotlight on Southeast Asia as “unique” opportunity beckons
Southeast Asia offers a unique opportunity for sponsors conducting clinical trials with vaccine candidates including faster recruitment, lower costs, and …
-
Spyre Therapeutics begins dosing subjects in Phase I trials of anti-TL1A antibodies
US-based biotechnology company Spyre Therapeutics has begun dosing healthy volunteers in Phase I studies of two investigational monoclonal antibodies. The drug …
-
Delcath to trial Hepzato drug device combo in colorectal cancer
Delcath System has received clearance from the US Food and Drug Administration (FDA) for an investigational new drug (IND) application …
-
Medicus Pharma and Swanielle partner to expand BCC drug trial to Asia-Pacific
Canadian life sciences company Medicus Pharma has partnered with Japanese healthcare consultancy Swanielle to expand its Phase II clinical trial …
-
Sudo Biosciences begins trial of drug candidate for neuroinflammatory conditions
US-based biopharmaceutical company Sudo Biosciences has initiated a Phase I trial of SUDO-550, a drug candidate designed to treat neuroinflammatory …
-
Four oral GLP-1R products in Phase III trials as race intensifies
The popularity of GLP-1 receptor (GLP-1R) subcutaneous treatments for obesity has proved the demand for the drugs, but the lack …
-
Novocure seeks approval after pancreatic cancer wearable scores at Phase III
Novocure is seeking regulatory approval in the US, EU, Japan and other key markets after the Phase III PANOVA-3 pancreatic …
-
Sidra Medicine conducts paediatric congenital hyperinsulinism trial
Qatar Foundation member Sidra Medicine has conducted the industry-sponsored ‘sunRIZE’ trial for paediatric congenital hyperinsulinism. The first pharmaceutical trial comes after …
-
Cantargia doses first subject in expanded part of CAN10’s Phase I trial
Sweden-based Cantargia has commenced an expanded segment of the ongoing Phase I trial of its antibody, CAN10, with the first …
-
Minghui reports positive topline data from trial of MH004 for atopic dermatitis
Minghui Pharmaceutical has reported positive topline outcomes from the randomised Phase III trial of its pan-Jak inhibitor, MH004 (tofacitinib etocomil) …
-
‘Pill-on-a-thread’ cancer screening trial commences with first patients
A pivotal investigator-led clinical trial for a new ‘pill-on-a-thread’ innovation for oesophageal cancer screening has welcomed its first patients, Cambridge …
-
Tryptamine Therapeutics completes dosing in obesity trial of TRP-8803
Tryptamine Therapeutics (Tryp) has announced the completion of subject dosing in a Phase Ib clinical trial of its psilocin-based intravenous …
-
Albus demonstrates device’s ability to detect asthma attacks in children
UK-based Albus Health (formerly BreathOx) has shared data revealing that its Albus Home AI-powered monitoring device can detect warning signs …
-
Takeda Canada co-sponsors grant to boost IBD clinical research
Takeda Canada has co-sponsored the Canadian Inflammatory Bowel Disease Research Consortium (CIRC) PIONEER Grant to boost clinical research efforts. The company …
